Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$170.6M
1 round on record
Latest round
$170.6M
Venture round · Mar 2024 · 2 yr ago
Team
3
US Form 5500 (plan participants) · Dec 2025 · +50% in a year
The money's age
Long since its last round
30 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 21, 2024 Raised a round Venture round $170.6M · SEC Form D 2023 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Mar 2024 $170.6M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Endo, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Frank RacitiExecutive OfficerSEC Form D
Patrick BarryExecutive OfficerSEC Form D
Matthew MalettaExecutive OfficerSEC Form D
Blaise ColemanExecutive Officer, DirectorSEC Form D
Deanna VossExecutive OfficerSEC Form D
Mark BradleyExecutive Officer, DirectorSEC Form D
Similar startupsby what they do, their industry and backers
Home Customers Company Get Product Updates Recko has joined Stripe. Stay tuned for further product updates.
Buy FDA & GMP certified generic medicines online at PlatinumRx. Save up to 60% with pan-India delivery. Trusted by 10L+ customers for 100%…
Dawaa Dost5000+ employees
Dawaa Dost Pharmacy is No.1 Pharmacy in India that aims to make healthcare management affordable by providing high quality generic…
Quantum Pulse Ventures will be introducing it’s breakthrough technology for optical quantum computers. We believe photonics is the way to…
AlveusVenture round $160M · 8 mo ago • Founded 2014 • 11-50 employees
At Alveus Therapeutics, we are building a differentiated therapeutic portfolio that delivers sustainable weight loss with superior…
Empowering enterprises to build and scale AI-native applications - merging infrastructure and data.

Overview

Mallinckrodt and Endo are merging to create a leading global therapeutics company with branded and generic products. Stay tuned for updates.

People

Frank Raciti
Executive Officer
Patrick Barry
Executive Officer
Matthew Maletta
Executive Officer
Blaise Coleman
Executive Officer, Director
Deanna Voss
Executive Officer
Mark Bradley
Executive Officer, Director
Brian Morrissey
Executive Officer
Scott Hirsch
Director
Paul Efron
Director
Paul Herendeen
Director
Marc Yoskowitz
Director
Sophia Langlois
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Malvern United States
HQ
200-500 est. staff

Financials

Total raised
$170.6M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $170.6M Details